Janssen Global Services Overview
- Year Founded
-
1953

- Status
-
Acquired/Merged
- Employees
-
31,276

- Latest Deal Type
-
2ndary - Private
Janssen Global Services General Information
Description
Manufacturer of pharmaceutical products intended to improve the health of individuals living with serious conditions. The company engages in the research, development, manufacturing, and marketing of pharmaceutical products for a wide range of human medical disorders, including mental illness, neurological disorders, anesthesia, analgesia, gastrointestinal disorders, fungal infection, HIV/AIDS, allergies, and cancer, enabling customers to fight sickness with science, improving access with ingenuity.
Contact Information
Website
innovativemedicine.jnj.com(Operating Subsidiary)
Corporate Office
- 1000 U.S. Route 202 South
- Raritan, NJ 08869
- United States
Corporate Office
- 1000 U.S. Route 202 South
- Raritan, NJ 08869
- United States
Janssen Global Services Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
4. Secondary Transaction - Private | Completed | Generating Revenue | ||||
3. Later Stage VC | Completed | Generating Revenue | ||||
2. Later Stage VC | Completed | Generating Revenue | ||||
1. Merger/Acquisition | 01-Jan-1961 | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Janssen Global Services Comparisons
Industry
Financing
Details
Janssen Global Services Competitors (27)
One of Janssen Global Services’s 27 competitors is Pfizer Manufacturing Austria, a Corporation company based in Orth An Der Donau, Austria.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Pfizer Manufacturing Austria | Corporation | Orth An Der Donau, Austria | ||||
Boehringer Ingelheim | Corporation | Ingelheim Am Rhein, Germany | ||||
Genentech | Formerly VC-backed | South San Francisco, CA | ||||
Pfizer Pakistan | Corporation | Karachi, Pakistan | ||||
Allogene Therapeutics | Formerly VC-backed | South San Francisco, CA |
Janssen Global Services Patents
Janssen Global Services Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
EP-4478050-A1 | Method for quantifying bound acetate in glycoconjugates | Pending | 12-Jun-2023 | ||
US-20240400702-A1 | Pharmaceutical compositions comprising a bispecific bcma/cd3 antibody at high concentration | Pending | 09-May-2023 | ||
US-20240358754-A1 | Bcma-targeted car-t cell therapy for multiple myeloma | Pending | 19-Apr-2023 | ||
FR-3147947-A1 | Bcma-targeted car-t cell therapy for multiple myeloma | Pending | 19-Apr-2023 | ||
FR-3147946-A1 | Bcma-targeted car-t cell therapy for multiple myeloma | Pending | 19-Apr-2023 | A61K35/17 |
Janssen Global Services Signals
Janssen Global Services Former Investors (2)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Ben Franklin Technology Partners of Southeastern Pennsylvania | Accelerator/Incubator | Minority | ||
NB Capital | PE/Buyout | Minority |
Janssen Global Services Investments & Acquisitions (18)
Janssen Global Services’s most recent deal was a Seed Round with DEEP (Database Software) for . The deal was made on 23-Feb-2024.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
DEEP (Database Software) | 23-Feb-2024 | Seed Round | Other Healthcare Technology Systems | ||
MeiraGTx (Botaretigene Sparoparvovec) | 21-Dec-2023 | Secondary Transaction - Private | Buildings and Property | ||
Yumanity Therapeutics (YTX-7739 and Discovery-stage Neuroscience Product Candidates and Targets) | 06-Jun-2022 | Corporate Asset Purchase | Buildings and Property | ||
Anakuria Therapeutics | 02-Feb-2022 | Merger/Acquisition | Biotechnology | ||
Mirum Pharmaceuticals (Rare Pediatric Disease Priority Review Voucher) | 20-Dec-2021 | Corporate Asset Purchase | Buildings and Property |
Janssen Global Services FAQs
-
When was Janssen Global Services founded?
Janssen Global Services was founded in 1953.
-
Where is Janssen Global Services headquartered?
Janssen Global Services is headquartered in Raritan, NJ.
-
What is the size of Janssen Global Services?
Janssen Global Services has 31,276 total employees.
-
What industry is Janssen Global Services in?
Janssen Global Services’s primary industry is Pharmaceuticals.
-
Is Janssen Global Services a private or public company?
Janssen Global Services is a Private company.
-
What is Janssen Global Services’s current revenue?
The current revenue for Janssen Global Services is
. -
Who are Janssen Global Services’s investors?
Ben Franklin Technology Partners of Southeastern Pennsylvania and NB Capital have invested in Janssen Global Services.
-
Who are Janssen Global Services’s competitors?
Pfizer Manufacturing Austria, Boehringer Ingelheim, Genentech, Pfizer Pakistan, and Allogene Therapeutics are some of the 27 competitors of Janssen Global Services.
-
Who acquired Janssen Global Services?
Janssen Global Services was acquired by Johnson & Johnson.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »